Profile
Dr. Alexandre Kaoukhov is a Chief Medical Officer at Aslan Pharmaceuticals Ltd. Dr. Kaoukhov was previously employed as a Senior Vice President & Head-Clinical Development by Bioniz Therapeutics, Inc., a Head-Global Development by Almirall SA, and a Head-Global Development by Allergan, Inc. He received his doctorate degree from I.M.
Sechenov First Moscow State Medical University.
Alexandre Kaoukhov active positions
| Companies | Position | Start |
|---|---|---|
| ASLAN PHARMACEUTICALS LIMITED | Chief Tech/Sci/R&D Officer | 15/03/2022 |
Former positions of Alexandre Kaoukhov
| Companies | Position | End |
|---|---|---|
Bioniz Therapeutics, Inc.
Bioniz Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates clinical-stage biotechnology company | Corporate Officer/Principal | - |
| ALMIRALL, S.A. | Corporate Officer/Principal | 01/11/2020 |
| ALLERGAN, INC. | Corporate Officer/Principal | 01/01/2018 |
Training of Alexandre Kaoukhov
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Allergan, Inc.
Allergan, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Almirall SA
Almirall SA Pharmaceuticals: MajorHealth Technology Engages in the development, manufacture and sale of pharmaceuticals | Health Technology |
Bioniz Therapeutics, Inc.
Bioniz Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates clinical-stage biotechnology company | Commercial Services |
I.M. Sechenov First Moscow State Medical University
I.M. Sechenov First Moscow State Medical University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aslan Pharmaceuticals Ltd.
Aslan Pharmaceuticals Ltd. BiotechnologyHealth Technology Operates as biotechnology company which develops immuno-oncology agents and targeted therapies | Health Technology |
- Stock Market
- Insiders
- Alexandre Kaoukhov
















